Dermatology

Kim Kjoller, MD: BLA for Tralokinumab and the Next Steps

July 31, 2020

Video

The FDA will be working over the next few months to ensure tralokinumab is efficient for atopic dermatitis.

Kim Kjoller, MD: Comparing Tralokinumab to Other Agents for Atopic Dermatitis

July 31, 2020

Video

An expert explains differences between tralokinumab and other popular agents for atopic dermatitis.

FDA Expands Ustekinumab to Pediatric Plaque Psoriasis

July 31, 2020

Article

The expansion makes history for the injection biologic.

Kim Kjoller, MD: Results of Tralokinumab Trials

July 24, 2020

Video

Kim Kjøller, MD, breaks down the findings from ECZTRA1, 2, and 3.

Kim Kjoller, MD: Tralokinumab for Atopic Dermatitis

July 24, 2020

Video

Kim Kjøller, MD, discusses how tralokinumab can be used for the treatment of atopic dermatitis.

Upadacitinib Demonstrates Safety and Efficacy for Atopic Dermatitis

July 21, 2020

Article

Upadacitinib 15 mg and 30 mg outperformed placebo in Measure Up 2, the second part of a phase 3 study on the monotherapy.

Likelihood of Enanthem Among COVID-19 Patients with Skin Rash

July 16, 2020

Article

Of the 21 patients included in the study with COVID-19 and skin rash, 29% had enanthem.

Barriers Prevent Pediatricians from Implementing Peanut Allergy Guidelines

July 15, 2020

Article

Although a majority of pediatricians are aware of the guidelines, less than one-third of survey respondents report full implementation.

FDA Approves Guselkumab for Active Psoriatic Arthritis

July 14, 2020

Article

Guselkumab represents the first FDA approved medication for active psoriatic arthritis that selectively inhibits interleukin-23.

FDA Issues Complete Response Letter for VP-102 for Molluscum

July 14, 2020

Article

The FDA is looking for more information regarding aspects of the chemistry, manufacturing, and controls process for the drug-device combination

x